Clarity Pharmaceuticals Ltd (CU6.AX)
AUD 2.57
(-1.15%)
AUD 2.57
(-1.15%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -136.5 Million AUD | 26.32% |
| 2023 | -65.01 Million AUD | -17.49% |
| 2022 | -55.33 Million AUD | -555.72% |
| 2021 | -8.43 Million AUD | -60.27% |
| 2020 | -5.26 Million AUD | -35.34% |
| 2019 | -3.89 Million AUD | -131.98% |
| 2018 | -1.67 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -47.9 Million AUD | -26.11% |
| 2024 Q1 | -23.17 Million AUD | 58.12% |
| 2024 FY | -136.5 Million AUD | -109.96% |
| 2024 Q4 | -136.5 Million AUD | 0.0% |
| 2024 Q2 | -37.98 Million AUD | -63.89% |
| 2023 FY | -65.01 Million AUD | -17.49% |
| 2023 Q4 | -55.33 Million AUD | -77.29% |
| 2023 Q3 | -31.21 Million AUD | 58.87% |
| 2023 Q2 | -75.88 Million AUD | -31.09% |
| 2023 Q1 | -57.88 Million AUD | 37.31% |
| 2022 Q2 | -96.66 Million AUD | -100.7% |
| 2022 Q1 | -48.16 Million AUD | -470.73% |
| 2022 FY | -55.33 Million AUD | -555.72% |
| 2022 Q4 | -92.33 Million AUD | -66.86% |
| 2022 Q3 | -55.33 Million AUD | 42.75% |
| 2021 Q4 | -8.43 Million AUD | 0.0% |
| 2021 Q1 | -10.98 Million AUD | -108.64% |
| 2021 FY | -8.43 Million AUD | -60.27% |
| 2021 Q2 | -100.07 Million AUD | -810.97% |
| 2021 Q3 | -8.43 Million AUD | 91.57% |
| 2020 Q1 | 8.41 Million AUD | 0.0% |
| 2020 FY | -5.26 Million AUD | -35.34% |
| 2020 Q3 | -5.26 Million AUD | 0.0% |
| 2020 Q4 | -5.26 Million AUD | 0.0% |
| 2019 FY | -3.89 Million AUD | -131.98% |
| 2018 FY | -1.67 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AdAlta Limited | -845.17 Thousand AUD | -16051.21% |
| Acrux Limited | -1.45 Million AUD | -9262.528% |
| Amplia Therapeutics Limited | -1.82 Million AUD | -7385.542% |
| Biome Australia Limited | -1.56 Million AUD | -8634.646% |
| BTC Health Limited | -2.02 Million AUD | -6650.504% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | -4371.196% |
| CSL Limited | 15.76 Billion AUD | 100.866% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 25.402% |
| Noxopharm Limited | -2.31 Million AUD | -5784.05% |
| PharmAust Limited | -9.71 Million AUD | -1305.231% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | -2058.585% |
| Prescient Therapeutics Limited | -10.16 Million AUD | -1243.203% |
| PYC Therapeutics Limited | -65.76 Million AUD | -107.576% |
| Race Oncology Limited | -17.18 Million AUD | -694.153% |
| Starpharma Holdings Limited | -19.83 Million AUD | -588.31% |
| EZZ Life Science Holdings Limited | -18.89 Million AUD | -622.3% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | -72.121% |
| Memphasys Limited | 4.13 Million AUD | 3400.928% |
| Nyrada Inc. | -4.76 Million AUD | -2762.13% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -13799.266% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | -29.032% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -19138.126% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 2793.837% |
| Patrys Limited | -2.24 Million AUD | -5992.205% |
| Dimerix Limited | -21.99 Million AUD | -520.712% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | -698.559% |
| Orthocell Limited | -19.92 Million AUD | -585.106% |
| Imugene Limited | -91.56 Million AUD | -49.088% |
| Cynata Therapeutics Limited | -6.2 Million AUD | -2099.782% |
| Immutep Limited | -122.18 Million AUD | -11.716% |
| Arovella Therapeutics Limited | -12.71 Million AUD | -973.63% |
| Alterity Therapeutics Limited | -12.47 Million AUD | -993.809% |
| Nanollose Limited | -96.22 Thousand AUD | -141760.911% |
| Invex Therapeutics Ltd | -6.02 Million AUD | -2165.629% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | -2655.385% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -10922.664% |
| Biotron Limited | -386.06 Thousand AUD | -35257.932% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | -634.888% |
| Tissue Repair Ltd | -16.44 Million AUD | -730.273% |
| AnteoTech Limited | -5 Million AUD | -2629.281% |
| Hexima Limited | -2.22 Million AUD | -6031.74% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | -676.417% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | -3919.443% |
| Avecho Biotechnology Limited | -5.32 Million AUD | -2461.445% |
| Actinogen Medical Limited | -9.13 Million AUD | -1394.86% |
| Immuron Limited | -11.48 Million AUD | -1088.678% |
| Argenica Therapeutics Limited | -15.91 Million AUD | -757.843% |